# Brodalumab

## Lumicef 210mg/1.5mL inj

##### 臨採

| 藥品代碼   | ILUMI                                                                                                                                                                                                                                                                                                                                                                               |
|:-----------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Moderate to severe plaque psoriasis， pustular psoriasis.                                                                                                                                                                                                                                                                                                                           |
| 用法用量   | SC， 210 mg at weeks 0， 1， and 2， followed by 210 mg once every 2 weeks.                                                                                                                                                                                                                                                                                                         |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                        |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                        |
| 禁忌       | Crohn disease， Clinically significant hypersensitivity to brodalumab or any component of the formulation.                                                                                                                                                                                                                                                                          |
| 副作用     | Common Gastrointestinal: Diarrhea (2.2% ) Immunologic: Infectious disease (25.4% )， Mycosis (1.8% to 2.4% ) Musculoskeletal: Arthralgia (4.7% ) Neurologic: Headache (4.3% ) Respiratory: Pain in throat (2.1% ) Other: Fatigue (2.6% ) Serious Hematologic: Neutropenia， Grade 3 or greater (0.5% ) Neurologic: Cryptococcal meningitis Psychiatric: Suicidal thoughts， Suicide |
| 孕期建議   | Uknown 沒有資料                                                                                                                                                                                                                                                                                                                                                                     |
| 哺乳期建議 | Unknown 沒有資料                                                                                                                                                                                                                                                                                                                                                                    |

